Open access · OA
via Europe PMC
Body composition-defined sarcopenia phenotypes, diabetes complications, and CGM-derived glycemic profiles in frail older adults with diabetes: a cross-sectional study.
Guevara E, Simó-Servat A, Perea V, Quirós C, Puig-Jové C, Formiga F, Barahona MJ.
The journal of nutrition, health & aging · 2026
Abstract
<h4>Background and aims</h4>Sarcopenia in older adults with diabetes may encompass clinically distinct phenotypes. We examined whether body composition-defined phenotypes differed in diabetes complications, insulin resistance-related metabolic features, and continuous glucose monitoring (CGM)-derived glycemic profiles.<h4>Methods</h4>This cross-sectional study included 109 adults aged 70 years or older with diabetes and frailty. Sarcopenia was defined according to the European Working Group on Sarcopenia in Older People 2 criteria; adiposity was defined using body mass index, body fat percentage, and central obesity. Analyses were mainly descriptive; exploratory logistic regression assessed poor CGM time in range (TIR), defined as TIR below 70%.<h4>Results</h4>Sarcopenia was identified in 86 participants (78.9%). After exclusion of 2 participants in a small non-sarcopenic with adiposity subgroup, 107 participants formed three phenotypes. Sarcopenic obesity showed an insulin resistance-related cluster comprising greater central adiposity, higher triglycerides and TyG index, metabolic syndrome in all participants, and greater insulin requirements. Sarcopenia without adiposity showed more neuropathy, albuminuria, cerebrovascular disease, and lower TIR despite similar glycated hemoglobin. Glycated hemoglobin was the only independent correlate of poor TIR; phenotype was not significant overall.<h4>Conclusions</h4>Phenotypes showed distinct clinical, insulin resistance-related, and CGM profiles. These preliminary findings support phenotype-aware assessment but require confirmation in larger longitudinal studies before informing management.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1016/j.jnha.2026.100947
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
E, G., A, S., V, P., C, Q., C, P., F, F., & MJ., B. (2026). Body composition-defined sarcopenia phenotypes, diabetes complications, and CGM-derived glycemic profiles in frail older adults with diabetes: a cross-sectional study. <em>The journal of nutrition, health & aging</em>. https://doi.org/10.1016/j.jnha.2026.100947
Vancouver
E G, A S, V P, C Q, C P, F F, et al. Body composition-defined sarcopenia phenotypes, diabetes complications, and CGM-derived glycemic profiles in frail older adults with diabetes: a cross-sectional study. The journal of nutrition, health & aging. 2026. doi:10.1016/j.jnha.2026.100947.
BibTeX
@article{guevara2026Bodyco,
title = {Body composition-defined sarcopenia phenotypes, diabetes complications, and CGM-derived glycemic profiles in frail older adults with diabetes: a cross-sectional study.},
author = {Guevara E and Simó-Servat A and Perea V and Quirós C and Puig-Jové C and Formiga F and Barahona MJ.},
journal = {The journal of nutrition, health & aging},
year = {2026},
doi = {10.1016/j.jnha.2026.100947},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
2022
Open access · CC-BY
Clinical and Metabolic Characterization of Adults with Type 2 Diabetes by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort
2022
Open access · CC-BY
Clinical and Metabolic Characterization of Adults with Type 2 Diabetes by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort
2022
Open access · CC-BY
Clinical and Metabolic Characterization of Adults with Type 2 Diabetes by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort
Proceedings of the AAAI Symposium Series 2024
Open access · OA
DeepAge: Harnessing Deep Neural Network for Epigenetic Age Estimation From DNA Methylation Data of Human Blood Samples
Diabetes Care 2022
Open access · OA
Clinical and Metabolic Characterization of Adults With Type 2 Diabetes by Age in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) Cohort
Consorci Sanitari del Maresme 2017
Open access · US-GOV